Metabolites

Biotechgate Digital Partnering August 2023

The world of biotechnology is constantly evolving, with breakthroughs and innovations shaping the future of healthcare and life sciences. As August 2023 kicks off, so does an exciting event that brings together key players in the industry to foster collaboration, …

Read more

BIO International Convention 2023

We are excited to invite you to visit the Bicoll booth, 1435-12, at the German Pavilion during the upcoming BIO International Convention in Boston from June 5-8th, 2023. As a leading provider of innovative discovery services and technologies, we offer …

Read more

Patent granted

Dihydrochalcone Derivatives: Enhancing Flavor as Sweet Tasting and Sweet Modulating Agents WO2023065059A1 The present invention introduces a unique compound or mixture of compounds (formula I) designed to enhance and optimize the flavor of sweet substances. Its purpose is to elevate …

Read more

Fractionation and Extraction Optimization of Compounds

New publication on molecules “Fractionation and Extraction Optimization of Potentially Valuable Compounds and Their Profiling in Six Varieties of Two Nicotiana Species”. There is an increasingly urgent call to shift industrial processes from fossil fuel feedstock to sustainable bio-based resources. …

Read more

Bicoll as Partner of a € 2.7 M European-Funded Euro TransBio Program; Olnorme II Program Focuses on the Development of a New Class of Drug Candidates for the Prevention and Treatment of Cardio Metabolic Diseases with an Inflammatory Component

Munich, Germany – May 11, 2011 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry and medicinal chemistry to identify novel small molecules for drug discovery and related innovative fields, will be responsible for roughly …

Read more